GlassScriptPhysician profile
Landon Jay Wallace
NPI 1639481906
$3,191.11
in general payments reported to CMS, 2019-2025
17 companies · $551 in 2025
The $551 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $73.29 · 2021: $412 · 2022: $555 · 2023: $662 · 2024: $563 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,622 · Entertainment: $146 · Education: $7.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,621.87 |
| Entertainment | $146.49 |
| Education | $7.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $673.75 | 2023-2025 | Miebo, Infuse, Xiidra |
| Oyster Point Pharma, INC. | $332.46 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Glaukos Corporation | $331.19 | 2021-2022 | |
| Johnson & Johnson Vision Care, INC. | $317.20 | 2019-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $242.42 | 2019-2020 | |
| Harrow Eye, LLC | $216.51 | 2024-2025 | Vevye |
| Kala Pharmaceuticals, INC. | $196.75 | 2021-2022 | |
| Optos, INC. | $160.18 | 2020-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Tarsus Pharmaceuticals, INC. | $160.16 | 2025 | Xdemvy |
| Shire North American Group INC | $140.79 | 2019 | |
| Eyepoint US, INC. | $135.71 | 2023 | |
| Abbvie INC. | $103.80 | 2022 | |
| Novartis Pharmaceuticals Corporation | $84.92 | 2021-2023 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Coopervision INC. | $28.54 | 2022-2023 | Misight Contact Lens |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $14.25 | 2024 | Iyuzeh |
| Eyevance Pharmaceuticals LLC | $13.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Landon Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.